Comparative guide · 6 min read

Maca vs Tongkat Ali for libido — non-hormonal vs hormonal mechanism, which fits you?

Updated 2026-05-18 · Reviewed by SupplementScore editors · No sponsorships

These two are the most-marketed botanical "libido" supplements, but they sit on opposite ends of the hormonal spectrum. Maca (Lepidium meyenii) has trial signals for subjective sexual desire that appear independent of androgen, oestrogen, or LH changes — making it the safer choice for cancer survivors, users on hormone-sensitive medications, and adults with unstable hormonal pictures. Tongkat ali (Eurycoma longifolia) acts via SHBG displacement and modest free-testosterone increases, with the strongest signal in men with subclinically low testosterone and clear hormonal mediation. Different mechanisms, different patients.

Quick verdict

SituationBetter choiceWhy
Postmenopausal low desireMacaSmall RCTs in postmenopausal women without hormonal change.
SSRI-induced sexual dysfunctionMacaOpen-label trial signal; saffron is another option.
Subclinical low testosterone (men, total T 250–350 ng/dL)Tongkat AliFree-T increase via SHBG displacement; modest libido signal.
Hypogonadism (total T <200 ng/dL)Neither — see endocrinologistSupplements will not correct true hypogonadism.
History of hormone-sensitive cancerMacaNon-hormonal mechanism; tongkat ali raises free T.
Stress-related desire decline (chronically high cortisol)Either; tongkat ali has cortisol-lowering signalTongkat ali reduces cortisol/T ratio in stressed cohorts.
Pregnancy or breastfeedingNeitherInadequate safety data for both.
Hypertension or BPHMaca (cautious)Tongkat ali androgenic profile may aggravate BPH.

How they compare on the things that matter

Mechanism — adaptogenic vs androgenic

Maca is a cruciferous Andean root with high-altitude growing requirements. The principal bioactives are macamides and macaenes (unique fatty acid amides), glucosinolates, and sterols. Trial-level effects on sexual desire have been consistently demonstrated without measurable changes in testosterone, LH, FSH, or oestradiol — the mechanism is not hormonal in the classical sense. Black, red, and yellow maca have slightly different traditional indications; black maca has the most consistent sperm and sexual-desire signal in available trials.

Tongkat ali (Eurycoma longifolia) contains quassinoids (eurycomanone, eurypeptides) that appear to displace testosterone from sex-hormone-binding globulin (SHBG), increasing free testosterone without necessarily increasing total testosterone. Multiple small RCTs show modest free-T increases (5–15%) and reductions in cortisol/T ratio under stress. Standardised extracts (LJ100, Physta) have the cleanest trial weight.

Evidence base by endpoint

Practical rule. If the goal is desire (libido) and you want to avoid hormonal modulation — postmenopausal women, cancer survivors, SSRI-treated patients, partners of users with hormone-sensitive concerns — start with maca. If the goal is specifically androgen-mediated (subclinical low T, exercise recovery in middle-aged men, the testosterone-curve flattening that often accompanies chronic stress in 40+ men), tongkat ali has the more specific mechanism. Both warrant an 8–12 week trial with explicit endpoint tracking.

Dose and form

For maca, 1.5–3 g/day of gelatinised (heat-treated, more digestible) maca powder, in divided doses with meals. Pre-toasting reduces glucosinolate content but improves tolerance. Trial doses run 1.5 g (Gonzales studies) to 3 g (Brooks postmenopausal trial). Black maca for sperm/sexual desire signal; red maca for prostate-related claims.

For tongkat ali, 200–400 mg/day of a standardised extract (LJ100 = 22% glycoprotein / 40% glycosaponin; Physta = 22% eurypeptides). Take in the morning. The "tribulus + tongkat" megacomplex products typically deliver sub-therapeutic doses of each.

Safety

Maca is generally well-tolerated. The main caution: heavy-metal contamination has been reported in low-grade product sources — choose third-party-tested brands. Pregnancy and breastfeeding data are inadequate; avoid. Some thyroid concern at very high chronic doses due to goitrogenic glucosinolates — modest doses in healthy thyroid users are not a documented problem.

Tongkat ali should be approached cautiously due to its androgenic mechanism. Avoid in: known or suspected hormone-sensitive cancers (prostate, breast), benign prostatic hyperplasia (theoretical aggravation), users on testosterone therapy or anti-androgens, pregnancy and breastfeeding, and users with severe hypertension. The long-term safety picture for daily use beyond 12 weeks is not well characterised.

What the price difference buys you

Gelatinised maca powder at 3 g/day runs $0.20–0.50/day. Standardised tongkat ali extract (LJ100 or Physta) at 400 mg/day runs $0.60–1.50/day. Generic "tongkat ali" supplements without standardisation are cheap but unreliable; the trial data are specifically for standardised extracts.

Who should skip each

Maca should be avoided in pregnancy and breastfeeding due to inadequate data. Cautious in known thyroid disease at very high chronic doses.

Tongkat ali should be avoided in: prostate cancer (or strong family history), breast cancer (or strong family history), benign prostatic hyperplasia, ongoing testosterone replacement therapy, anti-androgen therapy (e.g. for hair loss, prostate disease), severe hypertension, pregnancy and breastfeeding. The hormonal mechanism makes it a meaningfully higher-stakes supplement than maca.

What we'd actually buy

For non-hormonal libido support — postmenopausal women, cancer survivors, SSRI-treated patients, and adults who simply prefer non-hormonal approaches: gelatinised maca 1.5–3 g/day for 8 weeks with a clear endpoint (e.g., weekly self-rating on sexual interest). If no improvement at 8 weeks, the supplement is not the rate-limiting input.

For middle-aged men with documented subclinical low total testosterone (250–350 ng/dL) who are not in any of the contraindicated groups: standardised tongkat ali (LJ100 or Physta) 200–400 mg/day in the morning for 8–12 weeks, with baseline and follow-up labs (total T, free T, SHBG, oestradiol, PSA if appropriate by age). True hypogonadism warrants endocrinology evaluation, not supplementation.

Sources

Read more: